Sanofi-Aventis Signs Deal with ThalesNano

ThalesNano Inc. (Budapest), a developer of micro-scale flow instruments for chemistry, says it has signed an R&D agreement with Sanofi-Aventis (Paris) that will focus on continuous process chemistry technologies to reduce drug realization time. The...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers